Meeder Asset Management Inc. Raises Position in DaVita Inc. (NYSE:DVA)

Meeder Asset Management Inc. grew its position in DaVita Inc. (NYSE:DVA) by 34.0% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 591 shares of the company’s stock after purchasing an additional 150 shares during the quarter. Meeder Asset Management Inc.’s holdings in DaVita were worth $71,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. Amundi Pioneer Asset Management Inc. grew its position in DaVita by 31.9% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 154,693 shares of the company’s stock valued at $8,398,000 after buying an additional 37,375 shares during the period. Migdal Insurance & Financial Holdings Ltd. grew its position in DaVita by 29.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 623 shares of the company’s stock valued at $67,000 after buying an additional 143 shares during the period. Commonwealth Equity Services LLC grew its position in DaVita by 15.9% during the first quarter. Commonwealth Equity Services LLC now owns 19,243 shares of the company’s stock valued at $2,073,000 after buying an additional 2,635 shares during the period. Natixis Advisors L.P. grew its position in DaVita by 8.7% during the first quarter. Natixis Advisors L.P. now owns 64,404 shares of the company’s stock valued at $6,940,000 after buying an additional 5,137 shares during the period. Finally, IFM Investors Pty Ltd grew its position in DaVita by 34.6% during the first quarter. IFM Investors Pty Ltd now owns 10,633 shares of the company’s stock valued at $1,146,000 after buying an additional 2,732 shares during the period. 86.52% of the stock is owned by institutional investors and hedge funds.

In related news, Director Pamela M. Arway sold 365 shares of the company’s stock in a transaction on Monday, August 23rd. The shares were sold at an average price of $133.09, for a total transaction of $48,577.85. Following the sale, the director now owns 19,239 shares of the company’s stock, valued at $2,560,518.51. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Phyllis R. Yale sold 5,048 shares of the company’s stock in a transaction on Tuesday, June 22nd. The shares were sold at an average price of $124.33, for a total transaction of $627,617.84. Following the sale, the director now directly owns 14,125 shares in the company, valued at approximately $1,756,161.25. The disclosure for this sale can be found here. Insiders sold 43,963 shares of company stock worth $5,741,151 in the last three months. Insiders own 0.69% of the company’s stock.

Several analysts recently issued reports on the stock. William Blair restated a “market perform” rating on shares of DaVita in a research report on Wednesday, August 4th. Barclays reiterated an “equal weight” rating and issued a $146.00 price target (up from $135.00) on shares of DaVita in a research report on Thursday, August 12th. Deutsche Bank Aktiengesellschaft upped their price target on shares of DaVita from $150.00 to $207.00 and gave the stock a “buy” rating in a research report on Monday, July 19th. Finally, Cowen initiated coverage on shares of DaVita in a research report on Thursday, September 9th. They issued a “market perform” rating and a $145.00 price target for the company. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, DaVita has a consensus rating of “Hold” and a consensus price target of $143.83.

DVA stock opened at $122.33 on Wednesday. DaVita Inc. has a one year low of $80.85 and a one year high of $136.48. The company’s fifty day moving average price is $126.67 and its 200-day moving average price is $119.56. The company has a debt-to-equity ratio of 6.01, a quick ratio of 1.62 and a current ratio of 1.67. The company has a market capitalization of $12.82 billion, a PE ratio of 16.29, a price-to-earnings-growth ratio of 1.00 and a beta of 1.28.

DaVita (NYSE:DVA) last released its earnings results on Tuesday, August 3rd. The company reported $2.64 EPS for the quarter, topping the consensus estimate of $2.14 by $0.50. DaVita had a net margin of 7.47% and a return on equity of 61.00%. The firm had revenue of $2.92 billion for the quarter, compared to the consensus estimate of $2.88 billion. On average, research analysts predict that DaVita Inc. will post 9.22 EPS for the current fiscal year.

DaVita Company Profile

DaVita, Inc engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure.

Featured Story: Intrinsic Value and Stock Selection

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA).

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.